Skip to main content

Animations

MJFF Publications

1861 - 1870 of 8808 Results
Title
Year
  • Year
  • 2023
  • 2021
  • 2022
  • 2023
  • 2023
  • 2023
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Distribution of phosphorylated alpha-synuclein in non-diseased brain implicates olfactory bulb mitral cells in synucleinopathy pathogenesis
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00491-3
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awab170
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29164
    Citation Count: 12
  • Summary Details
    OPEN
    Title: The Foundational Data Initiative for Parkinson Disease: Enabling efficient translation from genetic maps to mechanism
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2023.100261
    Citation Count: 36
  • Summary Details
    OPEN
    Title: The AAA+ chaperone VCP disaggregates Tau fibrils and generates aggregate seeds in a cellular system
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-023-36058-2
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Time-resolved RNA signatures of CD4+ T cells in Parkinson’s disease
    Journal Name: Cell Death Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41420-023-01333-0
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Pathological structural conversion of α-synuclein at the mitochondria induces neuronal toxicity
    Journal Name: Nature Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41593-022-01140-3
    Citation Count: 172
  • Summary Details
    OPEN
    Title: The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.994114
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Detecting motor symptom fluctuations in Parkinson’s disease with generative adversarial networks
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00674-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Multi-predictor modeling for predicting early Parkinson’s disease and non-motor symptoms progression
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2022.977985
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.